BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35932554)

  • 1. Direct imaging and automatic analysis in tumor-on-chip reveal cooperative antitumoral activity of immune cells and oncolytic vaccinia virus.
    Mencattini A; Lansche C; Veith I; Erbs P; Balloul JM; Quemeneur E; Descroix S; Mechta-Grigoriou F; Zalcman G; Zaupa C; Parrini MC; Martinelli E
    Biosens Bioelectron; 2022 Nov; 215():114571. PubMed ID: 35932554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering oncolytic vaccinia virus with functional peptides through mild and universal strategy.
    Huang LL; Li X; Liu K; Zou B; Xie HY
    Anal Bioanal Chem; 2019 Feb; 411(4):925-933. PubMed ID: 30523361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy.
    Wang S; Li Y; Xu C; Dong J; Wei J
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38458640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review.
    Li M; Zhang M; Ye Q; Liu Y; Qian W
    Cancer Biol Med; 2023 Aug; 20(9):646-61. PubMed ID: 37615308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer.
    Sun F; Guo ZS; Gregory AD; Shapiro SD; Xiao G; Qu Z
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing therapeutic efficacy of oncolytic vaccinia virus armed with Beclin-1, an autophagic Gene in leukemia and myeloma.
    Lei W; Wang S; Xu N; Chen Y; Wu G; Zhang A; Chen X; Tong Y; Qian W
    Biomed Pharmacother; 2020 May; 125():110030. PubMed ID: 32187960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in combination therapy of oncolytic vaccinia virus.
    Mirbahari SN; Da Silva M; Zúñiga AIM; Kooshki Zamani N; St-Laurent G; Totonchi M; Azad T
    Front Immunol; 2024; 15():1272351. PubMed ID: 38558795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic vaccinia virus and cancer immunotherapy.
    Xu L; Sun H; Lemoine NR; Xuan Y; Wang P
    Front Immunol; 2023; 14():1324744. PubMed ID: 38283361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA UCA1 enhances sensitivity to oncolytic vaccinia virus by sponging miR-18a/miR-182 and modulating the Cdc42/filopodia axis in colorectal cancer.
    Horita K; Kurosaki H; Nakatake M; Ito M; Kono H; Nakamura T
    Biochem Biophys Res Commun; 2019 Aug; 516(3):831-838. PubMed ID: 31262449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8
    Wei W; Tian L; Zheng X; Zhong L; Chen Y; Dong H; Zhang G; Wang S; Tong X
    Oncoimmunology; 2024; 13(1):2322173. PubMed ID: 38419758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic vaccinia virus acts synergistically with anti-PD-L1 antibody to enhance the killing of colon cancer cells by CD8
    Wu R; Tong S; Yin J; Zhu Z; Mao Z; Xu L
    Pathol Res Pract; 2023 Jul; 247():154535. PubMed ID: 37257241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia.
    Wang W; Liu S; Dai P; Yang N; Wang Y; Giese RA; Merghoub T; Wolchok J; Deng L
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers.
    Draganov DD; Santidrian AF; Minev I; Nguyen D; Kilinc MO; Petrov I; Vyalkova A; Lander E; Berman M; Minev B; Szalay AA
    J Transl Med; 2019 Mar; 17(1):100. PubMed ID: 30917829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
    Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
    EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphoma.
    Lei W; Ye Q; Hao Y; Chen J; Huang Y; Yang L; Wang S; Qian W
    Blood Cancer J; 2022 Feb; 12(2):35. PubMed ID: 35228544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms.
    Kloker LD; Berchtold S; Smirnow I; Beil J; Krieg A; Sipos B; Lauer UM
    BMC Cancer; 2020 Jul; 20(1):628. PubMed ID: 32631270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in Lymphoma.
    Wang P; Wu Y; Yang C; Zhao G; Liu Y; Cheng G; Wang S
    Onco Targets Ther; 2020; 13():1421-1429. PubMed ID: 32110041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viruses as nanomedicine for cancer.
    Badrinath N; Heo J; Yoo SY
    Int J Nanomedicine; 2016; 11():4835-4847. PubMed ID: 27703350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivo.
    Xie S; Fan W; Yang C; Lei W; Pan H; Tong X; Wu Y; Wang S
    Oncol Rep; 2021 Mar; 45(3):987-996. PubMed ID: 33469679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.